Michael Humphries

Dr. Humphries most recently served as Chief Medical Officer and Head of Development Strategy at CellularBioMedicine Group in Shanghai, where he was responsible for the clinical development of various cell-based therapies. From 2004 until 2018, Dr. Humphries held various senior leadership roles at Novartis including Chief Scientific Officer at Novartis Development China. He previously held the role of Country Medical Director at GlaxoWellcome/GSK China from 1998 to 2004, and from 1990 until 1998, Dr. Humphries was Regional Medical Director, Roche China/Hong Kong/Asia-Pacific. Dr. Humphries studied medicine at the University of Cambridge, before attending Guy’s Hospital Medical School, University of London. He is a Fellow of the Royal College of Physicians, while also holding other Fellowships at the Hong Kong College of Physicians and Hong Kong Academy of Medicine. He was formerly an Honorary Adjunct Professor at both the Faculty of Medicine Hong Kong University (medicine, microbiology) and the Chinese University of Hong Kong (medicine, public health). Following residency appointments in London and a research appointment at the UK Medical Research Council, he moved to Hong Kong in 1984 and was subsequently appointed Consultant Chest Physician to the Ruttonjee Hospital.